药物对比
比较 Exenatide（注射用GLP-1）与 Acarbose（口服）治疗2型糖尿病。作用机制、副作用及患者适用性的主要区别。
此页面暂无可用的对比维度。
临床背景
When type 2 diabetes patients weigh injectable GLP-1 agonists against oral alpha-glucosidase inhibitors.
结论
Exenatide and Acarbose suit different patients based on administration route, efficacy needs, and side-effect profiles rather than one being superior.